Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

GlaxoSmithKline AS

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 1,038,773 Less Arrow 903,088 Less Arrow 853,015
Financial expenses 1,918 Less Arrow 886 Less Arrow 303
Earnings before taxes 34,884 Less Arrow 27,789 More Arrow 27,949
Total assets 316,729 Less Arrow 292,017 Less Arrow 272,133
Current assets 232,182 Less Arrow 210,343 Less Arrow 195,315
Current liabilities 198,628 Less Arrow 175,730 Less Arrow 155,846
Equity capital 118,102 Less Arrow 116,287 Equal arrow 116,287
- share capital 950 Equal arrow 950 Equal arrow 950

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 37.3% More Arrow 39.8% More Arrow 42.7%
Turnover per employee
Profit as a percentage of turnover 3.4% Less Arrow 3.1% More Arrow 3.3%
Return on assets (ROA) 11.6% Less Arrow 9.8% More Arrow 10.4%
Current ratio 116.9% More Arrow 119.7% More Arrow 125.3%
Return on equity (ROE) 29.5% Less Arrow 23.9% More Arrow 24.0%
Change turnover 135,685 Less Arrow 50,073 More Arrow 70,849
Change turnover % 15% Less Arrow 6% More Arrow 9%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.